Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Proc Natl Acad Sci U S A ; 120(30): e2213697120, 2023 07 25.
Artigo em Inglês | MEDLINE | ID: mdl-37463199

RESUMO

Insights from biomedical citation networks can be used to identify promising avenues for accelerating research and its downstream bench-to-bedside translation. Citation analysis generally assumes that each citation documents substantive knowledge transfer that informed the conception, design, or execution of the main experiments. Citations may exist for other reasons. In this paper, we take advantage of late-stage citations added during peer review because these are less likely to represent substantive knowledge flow. Using a large, comprehensive feature set of open access data, we train a predictive model to identify late-stage citations. The model relies only on the title, abstract, and citations to previous articles but not the full-text or future citations patterns, making it suitable for publications as soon as they are released, or those behind a paywall (the vast majority). We find that high prediction scores identify late-stage citations that were likely added during the peer review process as well as those more likely to be rhetorical, such as journal self-citations added during review. Our model conversely gives low prediction scores to early-stage citations and citation classes that are known to represent substantive knowledge transfer. Using this model, we find that US federally funded biomedical research publications represent 30% of the predicted early-stage (and more likely to be substantive) knowledge transfer from basic studies to clinical research, even though these comprise only 10% of the literature. This is a threefold overrepresentation in this important type of knowledge flow.


Assuntos
Pesquisa Biomédica , Revisão por Pares
2.
Lancet Glob Health ; 10(11): e1684-e1687, 2022 11.
Artigo em Inglês | MEDLINE | ID: mdl-36240832

RESUMO

Scientists have expressed concern that the risk of flawed decision making is increased through the use of preprint data that might change after undergoing peer review. This Health Policy paper assesses how COVID-19 evidence presented in preprints changes after review. We quantified attrition dynamics of more than 1000 epidemiological estimates first reported in 100 preprints matched to their subsequent peer-reviewed journal publication. Point estimate values changed an average of 6% during review; the correlation between estimate values before and after review was high (0·99) and there was no systematic trend. Expert peer-review scores of preprint quality were not related to eventual publication in a peer-reviewed journal. Uncertainty was reduced during peer review, with CIs reducing by 7% on average. These results support the use of preprints, a component of biomedical research literature, in decision making. These results can also help inform the use of preprints during the ongoing COVID-19 pandemic and future disease outbreaks.


Assuntos
Pesquisa Biomédica , COVID-19 , COVID-19/epidemiologia , Surtos de Doenças , Humanos , Pandemias , Revisão por Pares
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...